Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
加速药物合作计划®精神分裂症项目中的体液生物标志物与精神病风险:设计考量
期刊:npj Schizophrenia
影响因子:4.1
doi:10.1038/s41537-025-00610-4
Perkins, Diana O; Jeffries, Clark D; Clark, Scott R; Upthegrove, Rachel; Wannan, Cassandra M J; Wray, Naomi R; Li, Qingqin S; Do, Kim Q; Walker, Elaine; Paul Amminger, G; Anticevic, Alan; Cotter, David; Ellman, Lauren M; Mongan, David; Phassouliotis, Christina; Barbee, Jenna; Roth, Sharin; Billah, Tashrif; Corcoran, Cheryl; Calkins, Monica E; Cerrato, Felecia; Khadimallah, Ines; Klauser, Paul; Winter-van Rossum, Inge; Nunez, Angela R; Bleggi, Rachel S; Martin, Alicia R; Bouix, Sylvain; Pasternak, Ofer; Shah, Jai L; Toben, Catherine; Wolf, Daniel H; Kahn, Rene S; Kane, John M; McGorry, Patrick D; Bearden, Carrie E; Nelson, Barnaby; Shenton, Martha E; Woods, Scott W